Skip to content
value.today

Neon Therapeutics, Inc.

Total raised
$106 M
1 round on record
Latest round
$106 M
Dec 2016
First round on record
Dec 2016
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Neon Therapeutics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2016$106 MNo. 1$50 to $250 million

Neon Therapeutics, Inc.: Raise no. 1, Dec 2016

Investors in this round

25 investors had bought by the notice of Dec 13, 2017: 25 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 8 investors are named for Neon Therapeutics, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$106 M of $106 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Hugh Dowd · Executive Officer, Director
  • Richard Gaynor, M.D. · Executive Officer
  • Robert Ang, M.D. · Executive Officer
  • Yasir Al-Wakeel · Executive Officer
  • Cary Pfeffer, M.D. · Director
  • Eric Lander · Director
  • Robert Kamen · Director
  • Robert Tepper · Director
  • Stephen Sherwin · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Yasir Al-Wakeel, Chief Financial Officer. Newest notice filed Dec 13, 2017 (1 amendment). Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Neon Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2017).

    SEC Form D · Dec 2017

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Dec 2017

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

8 named in official filings. Open an investor to see everything it has backed.

Investors in Neon Therapeutics, Inc.
InvestorKindAmountRoundRoleSource
Access Industries Holdings LLCOthernot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2018)SEC Form 3
Access Industries, LLCOthernot statednot statedHeld Series A and B preferred stock (Form 3, 2018)SEC Form 3
Access Industries Management, LLCFund or asset managernot statednot statedHeld Series A and B preferred stock (Form 3, 2018)SEC Form 3
Clal Biotechnology Industries Ltd.Companynot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2018)SEC Form 3
Hadley Harbor Master Investors (Cayman) L.P.Fund or asset managernot statednot statedHeld Series B preferred stock, 10% owner (Form 3, 2018)SEC Form 3
Third Rock Ventures GP III, L.P.Venture capitalnot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2018)SEC Form 3
Third Rock Ventures III, L.P.Venture capitalnot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2018)SEC Form 3
TRV GP III, LLCOthernot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2018)SEC Form 3

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Neon Therapeutics, Inc.
NameRoleNamed in
Hugh DowdExecutive officerDec 2017
Richard Gaynor, M.D.Executive officerDec 2017
Robert Ang, M.D.Executive officerDec 2017
Yasir Al-WakeelExecutive officerDec 2017
Daniella BeckmanExecutive officerJan 2017
Cary Pfeffer, M.D.DirectorDec 2017
Eric LanderDirectorDec 2017
Hugh DowdDirectorDec 2017
Robert KamenDirectorDec 2017
Robert TepperDirectorDec 2017
Stephen SherwinDirectorDec 2017